1-2 of 2
Ivo Talah Azeh
Close
Sort by
Journal Articles

ELN Treatment Milestones in Chronic Myeloid Leukemia Are Prognostic for Achieving Deep Molecular Response and Treatment-Free Remission in Routine Care: Results of the German CML Registry

Katharina Kohlbrenner, Norbert Galuschek, Alice Fabarius, Marcel Reiser, Klaus Fenchel, Eva Esseling, Thomas Göhler, Ralf-Bodo Kühn, Reinhard Depenbusch, Ivo Talah Azeh, Erik Engel, Richard Hansen, Mathias Hanel, Paul Jehner, Maisun Abu-Samra, Markus Ritter, Norbert Gattermann, Henning Pelz, Stefan Fuxius, Burkhard Oswald, Gabriela M Baerlocher, Tim H. Brümmendorf, Dominik Heim, Philipp le Coutre, Andreas Burchert, Dietger Niederwieser, Hans Tesch, Wolf-Karsten Hofmann, Andreas Hochhaus, Rüdiger Hehlmann, Susanne Saussele
Journal: Blood
Blood (2023) 142 (Supplement 1): 4539.
https://doi.org/10.1182/blood-2023-180730
Published: 2023
Journal Articles

Therapy in Patients with Chronic Myeloid Leukemia Outside of Clinical Trials: Results of the German CML-Registry (CML-VI)

Katharina Kohlbrenner, Norbert Galuschek, Alice Fabarius, Marcel Reiser, Klaus Fenchel, Eva Eßeling, Thomas Göhler, Thomas Geer, Reinhard Depenbusch, Ivo Talah Azeh, Erik Engel, Richard Hansen, Hans-Walter Lindemann, Jürgen Anhuf, Paul Jehner, Maisun Abu-Samra, Markus Ritter, Norbert Gattermann, Henning Pelz, Stefan Fuxius, Burkhard Oswald, Gabriela M Baerlocher, Tim H.H. Brummendorf, Dominik Heim, Philipp le Coutre, Andreas Burchert, Dietger Niederwieser, Hans Tesch, Wolf-Karsten Hofmann, Andreas Hochhaus, Rüdiger Hehlmann, Susanne Saussele
Journal: Blood
Blood (2022) 140 (Supplement 1): 947–949.
https://doi.org/10.1182/blood-2022-159412
Published: 2022